#microbicide

New forms of treatment and PrEP and, hopefully, an at least partially effective vaccine will be key to fighting the epidemic in the 2020s.

Researchers conducted a systematic review of 60 studies in search of answers.

The implant is infused with a drug meant to keep the immune cells that the virus targets in a resting state.

An analysis of a previous study of a tenofovir-based vaginal gel found that women with vaginal inflammation were less protected.

A one-month version of the ring is currently up for regulatory approval.

Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.

Here’s how you can take action to support rectal microbicide research.

An anti-HIV vaginal microbicide gel lowered risk among women with a healthier dominant bacterial population.

Researchers have made progress in developing a microbicide enema that protects against contracting HIV through anal sex.

Scientists have made progress developing such a microbicide, with promising results in tests among monkeys.

All of the big HIV science revelations from the Conference on Retroviruses and Opportunistic Infections, including the PrEP failure case.

A trial of a Viread (tenofovir)-containing vaginal gel to protect against HIV has failed because the South African women participants used it...

The NIH has awarded a $14.7 million grant to a team developing a microbicide with an HIV-fighting protein they will cultivate in tobacco plant...

An Isentress-containing microbicide gel prevents vaginal transmission of the simian cousin of HIV, SIV, when used as a post-exposure...

After many years of failures, recent studies have moved researchers closer to a form of HIV prevention that women can use discreetly.